Healthcare -
Biotechnology - NASDAQ - US
$ 74.17
1.57 %
$ 9.55 B
Market Cap
-19.52
P/E
Price Target
Average
85.31%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
7.30%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vaxcyte, Inc.
Wall Street analysts predict an average 1-year price target for PCVX of $137 , with forecasts ranging from
a
low of
$98 to a high of $163 .
PCVX Lowest Price Target
Wall Street Target
98 USD
32.13%
PCVX Average Price Target
Wall Street Target
137 USD
85.31%
PCVX Highest Price Target
Wall Street Target
163 USD
119.77%
REVENUE FORECAST
Revenue Forecast Chart PCVX
EBIT FORECAST
EBIT Forecast Chart PCVX
NET INCOME FORECAST
Net Income Chart PCVX